Journal article
Adherence to Therapy in Chronic Granulomatous Disease and Disease Outcomes: A Possibility for Development of New Therapeutic Delivery Devices
Journal of allergy and clinical immunology, v 135(2), pp AB103-AB103
01 Feb 2015
Abstract
Rationale Infections in chronic granulomatous disease (CGD) are prevented through the administration of antibiotic and antifungal agents in addition to subcutaneous interferon-γ (IFN- γ) therapy; however, medication adherence remains a barrier.
Metrics
17 Record Views
Details
- Title
- Adherence to Therapy in Chronic Granulomatous Disease and Disease Outcomes: A Possibility for Development of New Therapeutic Delivery Devices
- Creators
- Jasmeen Dara - Albert Einstein College of MedicineJessica Falcon - Temple UniversityJenny Shliozberg - Montefiore Medical CenterDaniel Conway - St. Christopher's Hospital for Children
- Publication Details
- Journal of allergy and clinical immunology, v 135(2), pp AB103-AB103
- Publisher
- Elsevier Limited
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Pediatrics
- Web of Science ID
- WOS:000361129600332
- Other Identifier
- 991021463672404721
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Allergy
- Immunology